EP1573015B1 - Cassette d'expression codant pour la 5-enolpyruvylshikimate-3-phosphate synthase (epsps) et plantes tolerantes aux herbicides en contenant - Google Patents
Cassette d'expression codant pour la 5-enolpyruvylshikimate-3-phosphate synthase (epsps) et plantes tolerantes aux herbicides en contenant Download PDFInfo
- Publication number
- EP1573015B1 EP1573015B1 EP03795982A EP03795982A EP1573015B1 EP 1573015 B1 EP1573015 B1 EP 1573015B1 EP 03795982 A EP03795982 A EP 03795982A EP 03795982 A EP03795982 A EP 03795982A EP 1573015 B1 EP1573015 B1 EP 1573015B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- epsps
- plants
- expression cassette
- sequence
- transformed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000014509 gene expression Effects 0.000 title claims description 74
- 108010020183 3-phosphoshikimate 1-carboxyvinyltransferase Proteins 0.000 title claims description 71
- 241000196324 Embryophyta Species 0.000 claims description 117
- 239000004009 herbicide Substances 0.000 claims description 43
- 238000000034 method Methods 0.000 claims description 33
- 210000004027 cell Anatomy 0.000 claims description 28
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical group OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 claims description 25
- 239000005562 Glyphosate Substances 0.000 claims description 24
- 229940097068 glyphosate Drugs 0.000 claims description 24
- 150000007523 nucleic acids Chemical group 0.000 claims description 23
- 230000002363 herbicidal effect Effects 0.000 claims description 22
- 108090000790 Enzymes Proteins 0.000 claims description 21
- 102000004190 Enzymes Human genes 0.000 claims description 21
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 20
- 240000008042 Zea mays Species 0.000 claims description 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 15
- 230000001105 regulatory effect Effects 0.000 claims description 15
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 14
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 14
- 235000009973 maize Nutrition 0.000 claims description 14
- 230000002401 inhibitory effect Effects 0.000 claims description 11
- 238000013518 transcription Methods 0.000 claims description 10
- 230000035897 transcription Effects 0.000 claims description 10
- 229940024606 amino acid Drugs 0.000 claims description 8
- 210000002706 plastid Anatomy 0.000 claims description 7
- 108700001094 Plant Genes Proteins 0.000 claims description 6
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 6
- 229960000310 isoleucine Drugs 0.000 claims description 6
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 6
- 239000012872 agrochemical composition Substances 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 4
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 4
- 239000004473 Threonine Substances 0.000 claims description 4
- 238000010367 cloning Methods 0.000 claims description 4
- 239000013599 cloning vector Substances 0.000 claims description 4
- 230000001276 controlling effect Effects 0.000 claims description 4
- 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 claims description 4
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 3
- 239000013604 expression vector Substances 0.000 claims description 2
- 238000003306 harvesting Methods 0.000 claims description 2
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 description 35
- 239000013598 vector Substances 0.000 description 19
- 241001515826 Cassava vein mosaic virus Species 0.000 description 18
- 108091033319 polynucleotide Chemical group 0.000 description 14
- 239000002157 polynucleotide Chemical group 0.000 description 14
- 102000040430 polynucleotide Human genes 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- 239000013612 plasmid Substances 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 10
- 230000009466 transformation Effects 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 7
- 230000035772 mutation Effects 0.000 description 7
- 244000038559 crop plants Species 0.000 description 6
- 241000589158 Agrobacterium Species 0.000 description 5
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 5
- 238000010369 molecular cloning Methods 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 108091026890 Coding region Proteins 0.000 description 4
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 238000003752 polymerase chain reaction Methods 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 229930182566 Gentamicin Natural products 0.000 description 3
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 3
- 108010033040 Histones Proteins 0.000 description 3
- 241000209510 Liliopsida Species 0.000 description 3
- 108010076504 Protein Sorting Signals Proteins 0.000 description 3
- 239000012190 activator Substances 0.000 description 3
- 210000002257 embryonic structure Anatomy 0.000 description 3
- 241001233957 eudicotyledons Species 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229960000210 nalidixic acid Drugs 0.000 description 3
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 108091092195 Intron Proteins 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 108091022908 Serine O-acetyltransferase Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000723792 Tobacco etch virus Species 0.000 description 2
- 241000723873 Tobacco mosaic virus Species 0.000 description 2
- 230000009418 agronomic effect Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 2
- 210000003763 chloroplast Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 230000000749 insecticidal effect Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 150000002545 isoxazoles Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 108010058731 nopaline synthase Proteins 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000010421 standard material Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000003934 vacuole Anatomy 0.000 description 2
- FQVLRGLGWNWPSS-BXBUPLCLSA-N (4r,7s,10s,13s,16r)-16-acetamido-13-(1h-imidazol-5-ylmethyl)-10-methyl-6,9,12,15-tetraoxo-7-propan-2-yl-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide Chemical compound N1C(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CC1=CN=CN1 FQVLRGLGWNWPSS-BXBUPLCLSA-N 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- QYOJSKGCWNAKGW-PBXRRBTRSA-K 3-phosphonatoshikimate(3-) Chemical compound O[C@@H]1CC(C([O-])=O)=C[C@@H](OP([O-])([O-])=O)[C@H]1O QYOJSKGCWNAKGW-PBXRRBTRSA-K 0.000 description 1
- QUTYKIXIUDQOLK-PRJMDXOYSA-N 5-O-(1-carboxyvinyl)-3-phosphoshikimic acid Chemical compound O[C@H]1[C@H](OC(=C)C(O)=O)CC(C(O)=O)=C[C@H]1OP(O)(O)=O QUTYKIXIUDQOLK-PRJMDXOYSA-N 0.000 description 1
- 101100001031 Acetobacter aceti adhA gene Proteins 0.000 description 1
- 102100034544 Acyl-CoA 6-desaturase Human genes 0.000 description 1
- 101150021974 Adh1 gene Proteins 0.000 description 1
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 1
- 241000589159 Agrobacterium sp. Species 0.000 description 1
- 101710120040 Antifungal peptide Proteins 0.000 description 1
- 241000219194 Arabidopsis Species 0.000 description 1
- 241001167018 Aroa Species 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 241000701489 Cauliflower mosaic virus Species 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 1
- 101150111720 EPSPS gene Proteins 0.000 description 1
- 235000007351 Eleusine Nutrition 0.000 description 1
- 241000209215 Eleusine Species 0.000 description 1
- 241000701484 Figwort mosaic virus Species 0.000 description 1
- 244000299507 Gossypium hirsutum Species 0.000 description 1
- 101150012639 HPPD gene Proteins 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 108010037138 Linoleoyl-CoA Desaturase Proteins 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 102000004020 Oxygenases Human genes 0.000 description 1
- 108090000417 Oxygenases Proteins 0.000 description 1
- 240000007377 Petunia x hybrida Species 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 108700005077 Viral Genes Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 101100339555 Zymoseptoria tritici HPPD gene Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 101150085125 apr gene Proteins 0.000 description 1
- -1 aromatic amino acids Chemical class 0.000 description 1
- 101150103518 bar gene Proteins 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000002361 compost Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 108010002685 hygromycin-B kinase Proteins 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000004492 nuclear pore Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000007129 protein targeting to mitochondrion Effects 0.000 description 1
- 230000007398 protein translocation Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 1
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000002377 thylakoid Anatomy 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000003253 viricidal effect Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8274—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
- C12N15/8275—Glyphosate
Definitions
- the present invention relates to a novel expression cassette comprising a nucleic acid sequence encoding a 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) and to its use for obtaining plants resistant to herbicides which inhibit this, in particular herbicides of the phosphonic acid family, in particular of the N-phophonomethylglycine family.
- EPSPS 5-enolpyruvylshikimate-3-phosphate synthase
- EPSPS is a plastid enzyme involved in the shikimate biosynthetic pathway, leading to the synthesis of aromatic amino acids.
- EPSPS is known to be the target enzyme for herbicides of the family of phosphonic acids of the phophonomethylglycine type.
- 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS)-inhibiting herbicides are well known as being highly effective foliar herbicides.
- the most well known herbicide of this herbicide class is glyphosate [N-(phosphonomethyl)glycine].
- Sulfonate or fosametine are also known.
- Glyphosate is characterized by a lack of selectivity for crop species and is, consequently, generally used under conditions in which there is no need for selectivity, for example as a total herbicide.
- plants tolerant to this herbicide have been developed by transformation of said plants with a gene encoding a glyphosate-tolerant EPSPS enzyme.
- Genes encoding glyphosate-tolerant EPSPS enzymes are in particular described in patent application EP 0837944 .
- glyphosate-tolerant maize and soybean are sold respectively under the trade marks Roundup-Ready CornTM and Roundup-Ready SoybeanTM. In this way, glyphosate can be applied to crops without affecting the crop plants which have been made tolerant thereto.
- the success of this strategy is essentially based on the quality and the quantity of expression of the enzyme in the tissues of the plant intended to be made tolerant.
- These parameters of quality and quantity of expression are controlled by the regulatory elements introduced into the expression cassette with the nucleic acid sequence encoding said EPSPS enzyme.
- the regulatory elements essential to an expression cassette are the promoter regulatory sequence and the terminator regulatory sequence.
- the expression cassettes can also contain a signal peptide or a transit peptide, and also a transcription activator element or enhancer.
- the regulatory element which contributes most to the quality and the quantity of expression of a protein encoded by a nucleic acid sequence in an expression cassette is the promoter.
- Identification of the promoter suitable for expression of a given protein also depends largely on the nature of said protein, and in particular on the desired quantity and quality of expression of said protein.
- Associated with a given promotor is a quantity of expression of the product encoded by the nucleic acid sequence which it controls, and also a quality, in particular spatiotemporal quality, of this expression.
- some promoters are constitutive and others inducible.
- An important characteristic for a promoter used in an expression cassette intended for the expression of an EPSPS enzyme in a plant is that it should allow a quantitative expression sufficient to confer tolerance to glyphosate on all the tissues of the plant which may be affected by this herbicide.
- the technical problem of the present invention consists in obtaining an expression cassette in which the promoter is particularly suitable for the quantitative and qualitative expression of an EPSPS enzyme in transformed plants, said expression cassette then conferring effective tolerance on said plants, with respect to a herbicide which inhibits this enzyme, in particular a herbicide of the phophonomethylglycine family, in particular glyphosate.
- Promoters which allow a high level of expression are generally promoters of highly expressed proteins.
- promoters which are commonly used promoters satisfying these criteria, mention may be made, by way of example, of bacterial promoters, such as that of the octopine synthase gene or that of the nopaline synthase gene, viral promoters, such as that of the gene controlling transcription of cauliflower mosaic virus 35S or 19S RNAs ( Odell et al., 1985, Nature, 313, 810-812 ), or promoters of the cassava vein mosaic virus (as described in patent application WO 97/48819 ).
- promoters of plant origin mention will be made of the promoter of the ribulose-biscarboxylase/oxygenase (RuBisCO) small subunit gene, the promoter of a histone gene described in application EP 0 507 698 , or the promoter of a rice actin gene ( US 5,641,876 ).
- RuBisCO ribulose-biscarboxylase/oxygenase
- promoters are expressed specifically in the cells of certain tissues. Such promoters are generally promoters which regulate the expression of proteins involved in the function of a particular tissue or organ.
- root-specific promoters such as, for example, that described in patent application WO 00/29594
- flower-specific promoters such as those described in patent applications WO 98/22593 , WO 99/15679 or WO 99/43818
- fruit-specific promoters in particular seed-specific promoters such as those described in patent applications WO 91/13993 , WO 92/17580 , WO 98/45460 , WO 98/45461 , or WO 99/16890 , are known.
- the present invention relates to a novel expression cassette comprising, in the direction of transcription, optionally linked to one another, a promoter regulatory sequence which is functional in plant cells or plants, a nucleic acid sequence encoding 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) and a terminator sequence which is functional in plant cells or plants, characterized in that the promoter regulatory sequence comprises, in the direction of transcription, the nucleic acid sequence x, y, y, z, whereby x is represented by SEQ ID NO: 1, y is represented by SED ID NO: 2, and z is represented by SEQ ID NO:3.
- EPSPS 5-enolpyruvylshikimate-3-phosphate synthase
- the expression “functionally linked to one another” means that said elements of the chimeric gene are linked to one another in such a way that their function is coordinated and allows expression of the coding sequence.
- a promoter is functionally linked to a coding sequence when it is capable of ensuring expression of said coding sequence.
- the construction of a chimeric gene according to the invention and the assembly of its various elements can be carried out using techniques well known to those skilled in the art, in particular those described in Sambrook et al. (1989, Molecular Cloning: A Laboratory Manual, Nolan C. ed., New York: Cold Spring Harbor Laboratory Press ).
- the expression “functional in plant cells and plants” is intended to mean capable of functioning in plant cells and plants.
- CsVMV promoter regulatory sequences are described in patent application WO 97/48819 , in particular the promoter regulatory sequence comprising one of the nucleotide sequences represented by one of the sequence identifiers SEQ ID Nos. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 or 16 of patent application WO 97/48819 , more particularly the nucleic acid sequence represented by the sequence identifier SEQ ID NO 3 of patent application WO 97/48819 .
- the promoter regulatory sequence is represented by SEQ ID NO 5 of the present application.
- the present invention also relates to the sequences capable of hybridizing selectively with the nucleic acid sequences above, the sequences homologous to the sequences above, and the functional fragments of said sequences.
- nucleic acid sequence is intended to mean a nucleotide or polynucleotide sequence which may be of the DNA or RNA type, preferably of the DNA type, in particular double-stranded.
- the expression "sequence capable of hybridizing selectively” is intended to mean the sequences which hybridize with the sequences above at a level significantly greater than the background noise.
- the background noise may be related to the hybridization of other DNA sequences present, in particular other cDNAs present in a cDNA library.
- the level of the signal generated by the interaction between the sequence capable of hybridizing selectively and the sequences defined by the SEQ IDs above according to the invention is generally 10 times, preferably 100 times, more intense than that of the interaction of the other DNA sequences generating the background noise.
- the level of interaction can be measured, for example, by labeling the probe with radioactive elements, such as 32 P.
- hybridization is generally obtained using very stringent medium conditions (for example 0.03 M NaCl and 0.03 M sodium citrate at approximately 50°C-60°C).
- very stringent medium conditions for example 0.03 M NaCl and 0.03 M sodium citrate at approximately 50°C-60°C.
- the hybridization can of course be carried out according to the usual methods of the state of the art (in particular Sambrook & al., 1989, Molecular Cloning: A Labratory Manual ).
- the term "homologue” is intended to mean a nucleic acid fragment exhibiting one or more sequence modifications relative to the nucleotide sequence encoding the fusion protein of the invention. These modifications may be obtained according to the usual mutation techniques, or else in choosing the synthetic oligonucleotides used in the preparation of said sequence by hybridization. With regard to the multiple combinations of nucleic acids which may lead to the expression of a same amino acid, the differences between the reference sequence according to the invention and the corresponding homologue may be considerable.
- the degree of homology will be at least 70% relative to the reference sequence, preferably at least 80%, more preferably at least 90%. These modifications are generally and preferably neutral, i.e. they do not affect the primary sequence of the fusion protein.
- fragments is intended to mean fragments of the DNA sequences according to the invention, i.e. the sequences above for which parts have been deleted but which conserve the function of said sequences.
- EPSPS is intended to mean any native or mutated 5-enolpyruvylshikimate-3-phosphate synthase enzyme, the enzymatic activity of which consists in synthesizing 5-O-(1-carboxyvinyl)-3-phosphoshikimate from phosphoenolpyruvate (PEP) and 3-phosphoshikimate (E.C. 2.5.1.19; Morell et al., 1967, J. Biol. Chem. 242, 82-90 ).
- said EPSPS enzyme may originate from any type of organism.
- An EPSPS enzyme according to the invention also has the property of being tolerant with respect to herbicides of the phophonomethylglycine family, in particular with respect to glyphosate.
- Sequences encoding EPSPSs which are naturally tolerant, or are used as such, with respect to herbicides of the phophonomethylglycine family, in particular glyphosate, are known.
- the sequence of the AroA gene of the bacterium Salmonella typhimurium Comai et al., 1983, Science 221, 370-371
- the sequence of the CP4 gene of the bacterium Agrobacterium sp. ( WO 92/04449 )
- sequences of the genes encoding Petunia EPSPS Shah et al., 1986, Science 233, 478-481
- Tomato EPSPS Gasser et al., 1988, J. Biol. Chem. 263,4280-4289
- Eleusine EPSPS WO 01/66704
- Sequences encoding EPSPSs made tolerant to glyphosate by mutation are also known.
- a sequence of a gene encoding a mutated plant EPSPS which is preferred according to the invention is that encoding the maize EPSPS described in patent application EP 0837944 , comprising a first mutation replacing the threonine amino acid at position 102 with isoleucine, and a second mutation replacing the proline amino acid at position 106 with serine. Due to the strong sequence homology between EPSPSs, and more particularly between plant EPSPSs, a rice EPSPS carrying the same mutations have also been described in patent applications WO 00/66746 and WO 00/66747 .
- any EPSPS, and the genes encoding them, carrying the threonine/isoleucine and proline/serine mutations described above, whatever the relative position of these amino acids with respect to positions 102 and 106 of maize EPSPS, can be used in the present invention.
- those skilled in the art will be readily able to find the two amino acids to be mutated in any EPSPS sequence by using standard techniques of sequence alignment.
- the nucleic acid sequence encoding an EPSPS included in the expression cassette is a sequence encoding an EPSPS which has been mutated at the amino acids corresponding to the threonine at position 102 and to the proline at position 106, said positions being relative with respect to the maize EPSPS sequence.
- the nucleic acid sequence encoding an EPSPS included in the expression cassette is a sequence encoding a mutated EPSPS comprising an isoleucine at position 102 and a serine at position 106, said positions being relative with respect to the maize EPSPS sequence.
- the nucleic acid sequence encoding an EPSPS included in the expression cassette is a sequence encoding maize mutated EPSPS comprising an isoleucine at position 102 and a serine at position 106.
- the expression cassette according to the invention may also comprise a subcellular addressing sequence encoding a signal peptide or transit peptide.
- a sequence located upstream or downstream of the nucleic acid sequence encoding the EPSPS, makes it possible to direct said EPSPS specifically into a cellular compartment of the host organism.
- the expression cassette may comprise a sequence encoding a signal peptide or a transit peptide for directing the EPSPS to a particular compartment of the cytoplasm, such as the mitochondria, the plasts, the endoplasmic reticulum or the vacuoles.
- the transit peptide may be a signal for chloroplastic or mitochondrial addressing, which is then cleaved in the chloroplasts or the mitochondria.
- the transit peptides may be either single or double transit peptides.
- the double transit peptides are optionally separated by an intermediate sequence, i.e. they comprise, in the direction of transcription, a sequence encoding a transit peptide of a plant gene encoding an enzyme which is located in plastids, a portion of sequence of the mature N-terminal portion of a plant gene encoding an enzyme which is located in plastids, and then a sequence encoding a second transit peptide of a plant gene encoding an enzyme which is located in plastids.
- Such double transit peptides are, for example, described in patent application EP 0 508 909 .
- the expression cassette may also comprise other regulatory sequences, which are located between the promoter and the coding sequence, such as transcription activators (enhancers), for instance the transcription activator of the tobacco mosaic virus (TMV) described in application WO 87/07644 , of the tobacco etch virus (TEV) described by Carrington & Freed, or of the figwort mosaic virus ( US 5 994 521 ), for example.
- transcription activators for instance the transcription activator of the tobacco mosaic virus (TMV) described in application WO 87/07644 , of the tobacco etch virus (TEV) described by Carrington & Freed, or of the figwort mosaic virus ( US 5 994 521 ), for example.
- the expression cassette according to the invention may also contain introns, in particular introns which promote gene expression in monocotyledon plants, such as intron 1 of the rice actin gene described in patent application WO 99/34005 , or the maize adh1 intron, or in dicotyledon plants, such as the Arabidopsis histone intron ( EP 0850311 ).
- introns in particular introns which promote gene expression in monocotyledon plants, such as intron 1 of the rice actin gene described in patent application WO 99/34005 , or the maize adh1 intron, or in dicotyledon plants, such as the Arabidopsis histone intron ( EP 0850311 ).
- the present invention also relates to a cloning an/or expression vector comprising an expression cassette according to the invention.
- the vector according to the invention is of use for transforming a host organism, in particular a plant, and expressing therein an EPSPS.
- This vector may be a plasmid, a cosmid, a bacteriophage or a virus.
- the vector for transforming plant cells or plants according to the invention is a plasmid.
- the main qualities of this vector should be an ability to maintain itself and to self-replicate in the cells of the host organism, in particular by virtue of the presence of an origin of replication, and to express therein an EPSPS.
- the vector used in the present invention also contains, in addition to the expression cassette according to the invention, another expression cassette containing a selection marker.
- This selection marker makes it possible to select the host organisms which have effectively been transformed, i.e. those which have incorporated the vector.
- the host organism to be transformed is a plant.
- markers containing genes resistant to antibiotics such as, for example, that of the hygromycin phosphotransferase gene ( Gritz et al., 1983, Gene 25:179-188 ), but also markers containing genes for tolerance to herbicides, such as the bar gene ( White et al., NAR 18:1062, 1990 ) for tolerance to bialaphos, the EPSPS gene ( EP 0837944 ) for tolerance to glyphosate or else the HPPD gene ( WO 96/38567 ) for tolerance to isoxazoles.
- the bar gene White et al., NAR 18:1062, 1990
- the EPSPS gene EP 0837944
- HPPD gene WO 96/38567
- selection marker genes are in particular described in patent applications WO 91/02071 , WO 95/06128 , WO 96/38567 , and WO 97/04103 .
- the present invention also relates to plant cells transformed with a vector as described above.
- the term "transformed plant cell” is intended to mean a plant cell which has incorporated into its genome the expression cassette according to the invention, and consequently produces an EPSPS.
- those skilled in the art may use one of the many known methods of transformation.
- One of these methods consists in bringing the plant cells to be transformed into contact with polyethylene glycol (PEG) and the vectors of the invention ( Chang and Cohen, 1979, Mol. Gen. Genet. 168(1), 111-115 ; Mercenier and Chassy, 1988, Biochimie 70(4), 503-517 ).
- Electroporation is another method, which consists in subjecting the plant cells or tissues to be transformed and the vectors of the invention to an electric field ( Andreason and Evans, 1988, Biotechniques 6(7), 650-660 ; Shigekawa and Dower, 1989, Aust. J. Biotechnol. 3(1), 56-62 ).
- Another method consists in directly injecting the vectors into the plant cells or the plant tissues by microinjection ( Gordon and Ruddle, 1985, Gene 33(2), 121-136 ).
- the "biolistic” method may be used. It consists in bombarding plant cells or plant tissues with particles onto which the vectors of the invention are absorbed ( Bruce et al., 1989, Proc. Natl. Acad. Sci.
- the transformation of the plant cells will be carried out using bacteria of the genus Agrobacterium, preferably by infection of the cells or tissues of said plants with A. tumefaciens ( Knopf, 1979, Subcell. Biochem. 6, 143-173 ; Shaw et al., 1983, Gene 23(3):315-330 ) or A. rhizogenes ( Bevan and Chilton, 1982, Annu. Rev. Genet. 16:357-384 ; Tepfer and Casse-Delbart, 1987, Microbiol. Sci.
- the transformation of plant cells with Agrobacterium tumefaciens is carried out according to the protocol described by Ishida et al. (1996, Nat. Biotechnol. 14(6), 745-750 ). Those skilled in the art will choose the appropriate method according to the nature of the plant cells to be transformed.
- a subject of the present invention is a method for producing plants tolerant to EPSPS-inhibiting herbicides, in particular to herbicides of the phophonomethylglycine family, in particular glyphosate.
- This method consists in regenerating transformed plants from the transformed plant cells described above.
- the transformed plants according to the invention contain an expression cassette according to the invention in their genome and express an EPSPS in their tissues.
- the present invention therefore comprises transformed plants comprising an expression cassette according to the invention, parts of these plants, and the descendants of these plants.
- the expression "part of these plants” is intended to mean any organ of these plants, whether aerial or subterranean.
- the aerial organs are the stems, the leaves and the flowers.
- the subterranean organs are mainly the roots, but they may also be tubers.
- the term “descendants” is intended to mean mainly the seeds containing the embryos derived from the reproduction of these plants with one another. By extension, the term “descendants” applies to all the seeds formed at each new generation derived from crosses between a plant and the plant transformed by the method according to the invention.
- a subject of the present invention is therefore transformed plants into the genome of which there is integrated at least one expression cassette according to the invention in a stable manner.
- the plants thus transformed are tolerant to EPSPS-inhibiting herbicides, in particular herbicides of the phophonomethylglycine family, in particular to glyphosate.
- the transformed plants according to the invention also include the transformed plants derived from growing and/or crossing the plants above, and also the seeds of such plants.
- the transformed cells and plants according to the invention may comprise, in addition to an expression cassette according to the invention, at least one other expression cassette containing a polynucleotide encoding a protein of interest.
- polynucleotides encoding a protein of interest mention may be made of polynucleotides encoding another enzyme for resistance to a herbicide, for example the polynucleotide encoding the bar enzyme ( White et al., NAR 18:1062, 1990 ) for tolerance to bialaphos, or the polynucleotide encoding the HPPD enzyme ( WO 96/38567 ; WO 99/24585 ; WO 99/24586 ) for tolerance to isoxazoles.
- polynucleotides for resistance to diseases may also be contained in these plants, for example a polynucleotide encoding the oxalate oxydase enzyme as described in patent application EP 0 531 498 or US patent 5,866,778 , or a polynucleotide encoding an antibacterial and/or antifungal peptide such as those described in patent applications WO 97/30082 , WO 99/24594 , WO 99/02717 , WO 99/53053 , and WO 99/91089 .
- SAT serine acetyltransferase
- the additional expression cassettes may be integrated by means of the vector according to the invention.
- the vector comprises the expression cassette according to the invention and at least one expression cassette encoding another protein of interest.
- the plants according to the invention may also be obtained by crossing parents, one carrying the expression cassette according to the invention, the other carrying another expression cassette encoding at least one other protein of interest.
- the transformed plants according to the invention may be monocotyledons or dicotyledons. Preferably, these plants are plants of agronomic interest.
- the monocotyledon plants are wheat, maize or rice, advantageously, the dicotyledon plants are oilseed rape, soybean, tobacco or cotton.
- the present invention also relates to a method for protecting crop plants with respect to EPSPS-inhibiting herbicides, in particular to herbicides of the phophonomethylglycine family, in particular to glyphosate, characterized in that said plants are transformed with a vector comprising an expression cassette according to the invention.
- the present invention also relates to a method for treating the plants according to the invention, characterized in that said plants are treated with EPSPS-inhibiting herbicide, in particular a herbicide of the phophonomethylglycine family, in particular glyphosate.
- EPSPS-inhibiting herbicide in particular a herbicide of the phophonomethylglycine family, in particular glyphosate.
- the present invention also relates to a method for controlling weeds in crops, characterized in that transformed plants comprising an expression cassette according to the invention are grown, and in that said plants are treated with an EPSPS-inhibiting herbicide, in particular a herbicide of the phophonomethylglycinse family, in particular glyphosate.
- an EPSPS-inhibiting herbicide in particular a herbicide of the phophonomethylglycinse family, in particular glyphosate.
- the present invention also relates to a method for growing transformed plants comprising an expression cassette according to the invention, characterized in that it consists in planting seeds of said transformed plants in an area of a field suitable for growing said plants, in applying to said area of said field an agrochemical composition, without substantially affecting said transformed seeds or said transformed plants, then in harvesting the plants grown when they have reached the desired maturity and, optionally in separating the seeds from the harvested plants.
- agrochemical composition is intended to mean any agrochemical composition comprising at least one active product having one of the following activities: herbicidal, fungicidal, bactericidal, virucidal or insecticidal.
- the agrochemical composition comprises at least one active product having at least one herbicidal activity, more preferably an EPSPS-inhibiting herbicide, in particular a herbicide of the phophonomethylglycine family, in particular glyphosate.
- the plasmid pILTAB 357 provided by The Scripps Research Institute (La Jolla, CA, USA) contains the following elements in a pBIN 19 vector (Clontech):
- CsVMV X Three regions have been defined in the CsVMV promoter sequence, called CsVMV X, CsVMV Y and CsVMV Z.
- the X and Y regions are adjacent and the Y and Z regions are separated by the 2 bp sequence AT.
- the cloning vector pRD 254 corresponds to the commercial vector pBlueScript II SK (-) (Clontech) which has undergone mutagenesis so as to replace the unique Sca I site contained in the ApR gene with a Pvu II site.
- the 532 bp contained between the Hind III and Xba I sites of pILTAB 357 were cloned into the cloning vector pRD 254, so as to obtain the plasmid pRD 257.
- the pSF29 cassette comprises the CsVMV promoter as described by the sequence identifier SEQ ID NO 4, the sequence encoding the optimized transit peptide (OTP) as defined in patent application EP 0508909 , the sequence encoding maize EPSPS comprising the mutations threonine102isoleucine and proline106serine as described in patent application EP 0837944 , and the nos terminator as described in Bevan et al. (1983, Nucleic Acids Res. 11(2), 369-385 ).
- OTP optimized transit peptide
- a shuttle plasmid is used to be recombined in the superbinary plasmid pTVK 291 (Jun et al., 1987). Recombination between the unique COS sites present on the two plasmids produces a single circular molecule corresponding to fusion of the two plasmids.
- Recombination between pSF29 and the superbinary plasmid pTVK 291 was obtained by three-parent crossing with DH5 alpha [pSF29], C2110 [pTVK 291], and the JC2073 strain ("helper" strain).
- the resulting plasmid is called pSFK29.
- the strain obtained, C2110 [pSFK29] was selected on LB medium containing the 3 antibiotics gentamycin, kanamycin and nalidixic acid.
- the nalidixic acid allows the selection of C2110 against DH5 alpha or JC2073; since C2110 contains a chromosomal resistance to nalidixic acid which cannot be transferred to the other strains during crossing.
- pSF29 cannot replicate in C2110, unless it has been recombined with pTVK 291, since C2110 contains the origin of replication RK2 carried by pTVK 291, but not the origin of replication pBR 322 carried by pSF29.
- the recombinant plasmid was then transferred into the Agrobacterium strain LBA 4404 via a second three-parent cross.
- the resultant strain, LBA 4404 [pSFK29] was selected on AB medium (selective for Agrobacterium) containing kanamycin and gentamycin.
- Example 4 Transformation of maize by Agrobacterium tumefaciens with a CsVMV-EPSPS expression cassette
- Transformation of the maize Zea mays by Agrobacterium is carried out according to the method described in Ishida, Y. et al., (1996, Nature Biotechnology, 14, 745-750 ).
- the disarmed Agrobacterium tumefaciens strain described in Example 3 is cocultured with immature maize embryos.
- a selection with 0.88 mM glyphosate is applied to the embryos.
- the transformation events obtained from the resistant calices are then back-crossed and their descendants are tested for glyphosate tolerance.
- Example 5 Tests for glyphosate tolerance of the transformation events
- a disparity in the number of tolerant plants for each event tested is due to the fact that these events are heterozygotes for the trait (the CsVMV-EPSPS expression cassette) and have one or more integration loci, and that some transformation events, by virtue of the position of insertion of the cassette, provide better expression of the EPSPS, and therefore better tolerance to glyphosate.
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Claims (15)
- Cassette d'expression comprenant dans le sens de la transcription, liées entre elles de manière fonctionnelle, une séquence de régulation promotrice fonctionnelle dans les cellules végétales ou les plantes, une séquence d'acide nucléique codant pour une 5-enol pyruvylshikimate-3-phosphate synthase (EPSPS) et une séquence de régulation terminatrice fonctionnelle dans les cellules végétales ou les plantes, caractérisée en ce que la séquence de régulation promotrice comprend dans le sens de la transcription les séquences d'acides nucléiques X, Y, Y et Z où X est représentée par la SEQ ID NO : 1, Y est représentée par la SEQ ID NO : 2 et Z est représentée par la SEQ ID NO : 3.
- Cassette d'expression selon la revendication 1, caractérisée en ce que la séquence de régulation promotrice est représentée par la SEQ ID NO : 5.
- Cassette d'expression selon l'une des revendications 1 ou 2, caractérisée en ce que la séquence d'acide nucléique codant pour une EPSPS est une séquence codant pour une EPSPS mutée au niveau des acides aminés correspondant à la thréonine en position 102 et à la proline en position 106, lesdites positions étant relatives par rapport à la séquence d'EPSPS de maïs.
- Cassette d'expression selon la revendication 3, caractérisée en ce que la séquence d'acide nucléique codant pour une EPSPS est la séquence codant pour une EPSPS mutée comprenant une isoleucine en position 102 et une sérine en position 106, lesdites positions étant relatives par rapport à la séquence d'EPSPS de maïs.
- Cassette d'expression selon la revendication 4, caractérisée en ce que la séquence d'acide nucléique codant pour une EPSPS mutée est la séquence codant pour une EPSPS mutée de maïs comprenant une isoleucine en position 102 et une sérine en position 106.
- Cassette d'expression selon l'une des revendications 1 à 5, caractérisée en ce qu'elle comprend en plus un peptide de transit double comprenant, dans le sens de la transcription, une séquence codant pour un peptide de transit d'un gène végétal codant pour une enzyme à localisation plastidiale, une partie de séquence de la partie mature N-terminale d'un gène végétal codant pour une enzyme à localisation plastidiale, puis une séquence codant pour un second peptide de transit d'un gène végétal codant pour une enzyme à localisation plastidiale.
- Vecteur de clonage et/ou d'expression pour la transformation de cellules végétales ou de plantes, caractérisé en ce qu'il comprend au moins une cassette d'expression selon l'une des revendications 1 à 6.
- Cellule végétale transformée, caractérisée en ce qu'elle comprend une cassette d'expression selon l'une des revendications 1 à 6.
- Plante transformée, caractérisée en ce qu'elle comprend une cassette d'expression selon l'une des revendications 1 à 6.
- Graine de plante transformée selon la revendication 11, caractérisée en ce qu'elle comprend une cassette d'expression selon la revendication 6.
- Procédé de traitement de plantes selon la revendication 9, caractérisé en ce que l'on traite lesdites plantes avec un herbicide inhibiteur de l'EPSPS.
- Procédé selon la revendication 11, caractérisé en ce que ledit herbicide inhibiteur de l'EPSPS est le glyphosate.
- Procédé de contrôle des plantes indésirables dans les cultures, caractérisé en ce que l'on cultive des plantes transformées selon la revendication 9, et que l'on traite lesdites plantes avec un herbicide inhibiteur de l'EPSPS.
- Procédé selon la revendication 13, caractérisé en ce que ledit herbicide inhibiteur de l'EPSPS est le glyphosate.
- Procédé de culture de plantes transformées selon la revendication 9, caractérisé en ce qu'il consiste à planter des graines desdites plantes transformées dans une surface d'un champ approprié pour la culture desdites plantes, à appliquer sur ladite surface dudit champ une composition agrochimique, sans affecter de manière substantielle lesdites graines ou lesdites plantes transformées, puis à récolter les plantes cultivées lorsqu'elles arrivent à la maturité souhaitée et éventuellement à séparer les graines des plantes récoltées.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10162097A EP2208791A1 (fr) | 2002-12-12 | 2003-12-10 | Cassette d'expression codant pour la 5-enol-pyruvateshikimate-3-phosphate synthase (EPSPS) et plantes tolérantes à l'herbicide la contenant |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0215695 | 2002-12-12 | ||
FR0215695A FR2848570B1 (fr) | 2002-12-12 | 2002-12-12 | Cassette d'expression codant pour une 5-enol pyruvylshikimate-3-phosphate synthase (epsps) et plantes tolerantes aux herbicides la contenant |
PCT/EP2003/015008 WO2004053134A1 (fr) | 2002-12-12 | 2003-12-10 | Cassette d'expression codant pour la 5-enolpyruvylshikimate-3-phosphate synthase (epsps) et plantes tolerantes aux herbicides en contenant |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1573015A1 EP1573015A1 (fr) | 2005-09-14 |
EP1573015B1 true EP1573015B1 (fr) | 2010-05-19 |
Family
ID=32338700
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10162097A Withdrawn EP2208791A1 (fr) | 2002-12-12 | 2003-12-10 | Cassette d'expression codant pour la 5-enol-pyruvateshikimate-3-phosphate synthase (EPSPS) et plantes tolérantes à l'herbicide la contenant |
EP03795982A Expired - Lifetime EP1573015B1 (fr) | 2002-12-12 | 2003-12-10 | Cassette d'expression codant pour la 5-enolpyruvylshikimate-3-phosphate synthase (epsps) et plantes tolerantes aux herbicides en contenant |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10162097A Withdrawn EP2208791A1 (fr) | 2002-12-12 | 2003-12-10 | Cassette d'expression codant pour la 5-enol-pyruvateshikimate-3-phosphate synthase (EPSPS) et plantes tolérantes à l'herbicide la contenant |
Country Status (11)
Country | Link |
---|---|
US (3) | US20060242727A1 (fr) |
EP (2) | EP2208791A1 (fr) |
CN (1) | CN1720330B (fr) |
AR (2) | AR042443A1 (fr) |
AT (1) | ATE468400T1 (fr) |
AU (1) | AU2003298258B2 (fr) |
CA (1) | CA2502428C (fr) |
DE (1) | DE60332650D1 (fr) |
ES (1) | ES2345147T3 (fr) |
FR (1) | FR2848570B1 (fr) |
WO (1) | WO2004053134A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2848570B1 (fr) * | 2002-12-12 | 2005-04-01 | Bayer Cropscience Sa | Cassette d'expression codant pour une 5-enol pyruvylshikimate-3-phosphate synthase (epsps) et plantes tolerantes aux herbicides la contenant |
CA2651428A1 (fr) * | 2006-05-12 | 2007-11-22 | Commonwealth Scientific And Industrial Research Organisation | Enzymes capables de degrader les herbicides |
EP2604694A1 (fr) * | 2011-12-14 | 2013-06-19 | Genoplante-Valor | Procédé d'amélioration de plantes |
CN103194465B (zh) * | 2012-01-10 | 2014-06-18 | 华中农业大学 | 5-烯醇丙酮莽草酸-3-磷酸合酶基因的分离 |
CN102643804B (zh) * | 2012-04-12 | 2014-04-02 | 北京奥瑞金种业股份有限公司 | 一种培育耐草甘膦转基因玉米的方法 |
CN105861541A (zh) * | 2016-06-21 | 2016-08-17 | 福建省农业科学院生物技术研究所 | 一种双表达盒高抗草甘膦载体及其在水稻上的应用 |
CN111394369B (zh) * | 2020-05-07 | 2022-03-22 | 海南波莲水稻基因科技有限公司 | 抗草甘膦epsps突变基因、含有该基因的植物遗传转化筛选载体及其应用 |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4945050A (en) | 1984-11-13 | 1990-07-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues and apparatus therefor |
GB8613481D0 (en) | 1986-06-04 | 1986-07-09 | Diatech Ltd | Translation of mrna |
US4971908A (en) | 1987-05-26 | 1990-11-20 | Monsanto Company | Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthase |
US5310667A (en) | 1989-07-17 | 1994-05-10 | Monsanto Company | Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthases |
EP0485506B1 (fr) | 1989-08-09 | 1997-11-12 | DeKalb Genetics Corporation | Procedes et compositions de production de mais fecond ainsique de ses cellules transformees de maniere stable |
US7705215B1 (en) | 1990-04-17 | 2010-04-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
US5641876A (en) | 1990-01-05 | 1997-06-24 | Cornell Research Foundation, Inc. | Rice actin gene and promoter |
AU7583691A (en) | 1990-03-05 | 1991-10-10 | Upjohn Company, The | Protein expression via seed specific regulatory sequences |
JP3173785B2 (ja) | 1990-08-31 | 2001-06-04 | モンサント カンパニー | グリホセート耐性5―エノールピルビルシキミ酸―3―ホスフェートシンターゼ |
US5866775A (en) | 1990-09-28 | 1999-02-02 | Monsanto Company | Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthases |
EP0636181B1 (fr) | 1991-02-25 | 2000-11-29 | Zeneca Limited | Utilisation d' un gene encodant oxalate oxydase pour la transformaton des plantes |
FR2673643B1 (fr) | 1991-03-05 | 1993-05-21 | Rhone Poulenc Agrochimie | Peptide de transit pour l'insertion d'un gene etranger dans un gene vegetal et plantes transformees en utilisant ce peptide. |
FR2673642B1 (fr) | 1991-03-05 | 1994-08-12 | Rhone Poulenc Agrochimie | Gene chimere comprenant un promoteur capable de conferer a une plante une tolerance accrue au glyphosate. |
FR2673644A1 (fr) | 1991-03-05 | 1992-09-11 | Rhone Poulenc Agrochimie | Sequence adn codant pour une oxalate oxydase et plantes transformees contenant cette sequence et resistantes au sclerotinia. |
IL101508A0 (en) | 1991-04-08 | 1992-12-30 | Rhone Poulenc Agrochimie | Chimeric plant genes based on upstream regulatory elements of helianthinin |
PH31293A (en) | 1991-10-10 | 1998-07-06 | Rhone Poulenc Agrochimie | Production of y-linolenic acid by a delta6-desaturage. |
FR2706909B1 (fr) | 1993-06-25 | 1995-09-29 | Rhone Poulenc Agrochimie | |
US5614313A (en) | 1994-07-07 | 1997-03-25 | Imperial Chemical Industries Plc | Polymeric film having a layer comprising calcined silicone particles and china clay particles |
FR2734842B1 (fr) | 1995-06-02 | 1998-02-27 | Rhone Poulenc Agrochimie | Sequence adn d'un gene de l'hydroxy-phenyl pyruvate dioxygenase et obtention de plantes contenant un gene de l'hydroxy-phenyl pyruvate dioxygenase, tolerantes a certains herbicides |
FR2736929B1 (fr) | 1995-07-19 | 1997-08-22 | Rhone Poulenc Agrochimie | Sequence adn isolee pouvant servir de zone de regulation dans un gene chimere utilisable pour la transformation des plantes |
FR2736926B1 (fr) * | 1995-07-19 | 1997-08-22 | Rhone Poulenc Agrochimie | 5-enol pyruvylshikimate-3-phosphate synthase mutee, gene codant pour cette proteine et plantes transformees contenant ce gene |
FR2745004B1 (fr) | 1996-02-16 | 1998-03-27 | Rhone Poulenc Agrochimie | Peptide antibacterien et antifongique |
CA2258565C (fr) | 1996-06-20 | 2011-11-22 | The Scripps Research Institute | Promoteurs du virus de la mosaique des nervures du manioc et leurs utilisations |
US5994521A (en) | 1996-07-03 | 1999-11-30 | University Of Kentucky Research Foundation | Full length transcript (FLt) promoter from figwort mosaic caulimovirus (FMV) and use to express chimeric genes in plant cells |
US5955361A (en) | 1996-11-20 | 1999-09-21 | Pioneer Hi-Bred International, Inc. | P gene promoter constructs for floral-tissue preferred gene expression |
JP2001522233A (ja) | 1997-03-13 | 2001-11-13 | マイコーゲン コーポレーション | バチルス・チューリンギエンシス毒素 |
US5977436A (en) | 1997-04-09 | 1999-11-02 | Rhone Poulenc Agrochimie | Oleosin 5' regulatory region for the modification of plant seed lipid composition |
US5959175A (en) | 1997-04-09 | 1999-09-28 | Thomas; Terry L. | Sunflower albumin 5' regulatory region for the modification of plant seed lipid composition |
IL132148A0 (en) | 1997-04-11 | 2001-03-19 | Calgene Llc | Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants |
US5968809A (en) | 1997-04-11 | 1999-10-19 | Abbot Laboratories | Methods and compositions for synthesis of long chain poly-unsaturated fatty acids |
FR2766207B1 (fr) | 1997-07-11 | 2000-12-08 | Rhone Poulenc Agrochimie | Gene chimere codant pour la drosomycine, vecteur le contenant pour la transformation des cellules vegetales et plantes transformees obtenues resistantes aux maladies |
US6037150A (en) | 1997-08-21 | 2000-03-14 | University Technologies International Inc. | Insect sequences for improving the efficiency of secretion of non-secreted proteins in eukaryotic cells |
FR2768746B1 (fr) | 1997-09-23 | 2001-06-08 | Agronomique Inst Nat Rech | Promoteur specifique des petales et procede d'obtention de plantes a fleurs sans petale |
CA2305628C (fr) | 1997-09-30 | 2008-08-26 | The Regents Of The University Of California | Fabrication de proteines dans des graines de plantes |
FR2770853B1 (fr) | 1997-11-07 | 1999-12-31 | Rhone Poulenc Agrochimie | Gene codant pour la thanatine, vecteur le contenant et plantes transformees obtenues resistantes aux maladies |
FR2770854B1 (fr) | 1997-11-07 | 2001-11-30 | Rhone Poulenc Agrochimie | Sequence adn d'un gene de l'hydroxy-phenyl pyruvate dioxygenase et obtention de plantes contenant un tel gene, tolerantes aux herbicides |
FR2772787B1 (fr) | 1997-12-24 | 2001-12-07 | Rhone Poulenc Agrochimie | Promoteur h3c4 de mais associe au premier intron de l'actine de riz, gene chimere le comprenant et plante transformee |
KR20010012118A (ko) | 1998-02-25 | 2001-02-15 | 미즈노 마사루 | 꽃 기관에서 우세한 유전자발현을 명령하는 신규한 디엔에이 단편 |
FR2777568B1 (fr) | 1998-04-15 | 2002-10-31 | Rhone Poulenc Agrochimie | Gene codant pour l'heliomicine, proteine obtenue, vecteur le contenant, organismes transformes obtenus et procede de preparation |
ATE319847T1 (de) | 1998-07-07 | 2006-03-15 | Verfahren zur erhöhung des gehaltes an schwefelverbindungen in pflanzen | |
WO2000029594A1 (fr) | 1998-11-16 | 2000-05-25 | Advanta Technology Limited | Promoteur specifique des racines |
FR2787466B1 (fr) | 1998-12-17 | 2001-02-16 | Rhone Poulenc Agrochimie | Procede pour augmenter la teneur en cysteine, methionine et glutathion chez les plantes et plantes obtenues |
WO2000066746A1 (fr) | 1999-04-29 | 2000-11-09 | Syngenta Limited | Plantes resistant aux herbicides |
CZ20013856A3 (cs) | 1999-04-29 | 2002-04-17 | Syngenta Ltd. | Herbicidně rezistentní rostliny |
US6664384B1 (en) * | 1999-08-19 | 2003-12-16 | Profigen, Inc. | Duplicated cassava vein mosaic virus enhancers and uses thereof |
CA2401093A1 (fr) | 2000-03-09 | 2001-09-13 | Monsanto Technology Llc | Procedes permettant de rendre des plantes tolerantes au glyphosate et compositions associees |
FR2815969B1 (fr) | 2000-10-30 | 2004-12-10 | Aventis Cropscience Sa | Plantes tolerantes aux herbicides par contournement de voie metabolique |
EP1360310A2 (fr) * | 2001-02-13 | 2003-11-12 | University Of Florida | Double complexe promoteur bidirectionnel a activite promotrice amelioree dans le cadre de l'expression transgenique dans les eucaryotes |
FR2848570B1 (fr) * | 2002-12-12 | 2005-04-01 | Bayer Cropscience Sa | Cassette d'expression codant pour une 5-enol pyruvylshikimate-3-phosphate synthase (epsps) et plantes tolerantes aux herbicides la contenant |
-
2002
- 2002-12-12 FR FR0215695A patent/FR2848570B1/fr not_active Expired - Fee Related
-
2003
- 2003-12-10 EP EP10162097A patent/EP2208791A1/fr not_active Withdrawn
- 2003-12-10 AT AT03795982T patent/ATE468400T1/de not_active IP Right Cessation
- 2003-12-10 US US10/538,438 patent/US20060242727A1/en not_active Abandoned
- 2003-12-10 EP EP03795982A patent/EP1573015B1/fr not_active Expired - Lifetime
- 2003-12-10 AU AU2003298258A patent/AU2003298258B2/en not_active Ceased
- 2003-12-10 WO PCT/EP2003/015008 patent/WO2004053134A1/fr not_active Application Discontinuation
- 2003-12-10 CN CN2003801051477A patent/CN1720330B/zh not_active Expired - Fee Related
- 2003-12-10 CA CA2502428A patent/CA2502428C/fr not_active Expired - Fee Related
- 2003-12-10 ES ES03795982T patent/ES2345147T3/es not_active Expired - Lifetime
- 2003-12-10 DE DE60332650T patent/DE60332650D1/de not_active Expired - Lifetime
- 2003-12-11 AR ARP030104582A patent/AR042443A1/es not_active Application Discontinuation
-
2009
- 2009-09-29 US US12/569,068 patent/US8536408B2/en active Active
-
2012
- 2012-08-21 AR ARP120103059A patent/AR110801A2/es not_active Application Discontinuation
- 2012-12-28 US US13/730,638 patent/US9464298B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20130117893A1 (en) | 2013-05-09 |
CA2502428C (fr) | 2017-01-17 |
AU2003298258A1 (en) | 2004-06-30 |
ATE468400T1 (de) | 2010-06-15 |
FR2848570A1 (fr) | 2004-06-18 |
EP1573015A1 (fr) | 2005-09-14 |
CN1720330B (zh) | 2012-01-11 |
AR042443A1 (es) | 2005-06-22 |
DE60332650D1 (de) | 2010-07-01 |
EP2208791A1 (fr) | 2010-07-21 |
WO2004053134A1 (fr) | 2004-06-24 |
US20100105560A1 (en) | 2010-04-29 |
FR2848570B1 (fr) | 2005-04-01 |
US9464298B2 (en) | 2016-10-11 |
CA2502428A1 (fr) | 2004-06-24 |
AR110801A2 (es) | 2019-05-08 |
CN1720330A (zh) | 2006-01-11 |
US8536408B2 (en) | 2013-09-17 |
ES2345147T3 (es) | 2010-09-16 |
AU2003298258B2 (en) | 2009-10-29 |
US20060242727A1 (en) | 2006-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9464298B2 (en) | Expression cassette encoding a 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) and herbicide-tolerant plants containing it | |
AU2010246509B2 (en) | Plants and cells comprising polynucleotides to reduce transgene silencing | |
JP4879969B2 (ja) | 新規なクラスのepspシンターゼの同定 | |
EP1632576A2 (fr) | Nouvelles constructions d'expréssion végétales | |
CA2516221A1 (fr) | 5-enolpyruvylshikimate-3-phosphate synthase (epsps) de classe i resistante au glyphosate | |
BRPI0712991A2 (pt) | polinucleotìdeo isolado, método de produção de uma planta transformada que mostra toleráncia a glifosato, célula vegetal e planta tolerantes a glifosato, semente transformada, método para controlar seletivamente ervas daninhas, moléculas de ácido nucléico isolada e planta | |
AU759003B2 (en) | Maize H3C4 promoter associated with first rice actin intron, chimeric gene containing it and transformed plant | |
JP6463724B2 (ja) | 構成ダイズプロモーター | |
US11549123B2 (en) | Plant EPSP synthases and methods of use | |
CN110628733B (zh) | 除草剂耐受性蛋白质、其编码基因及用途 | |
CN111304178B (zh) | 除草剂耐受性蛋白质、其编码基因及用途 | |
CN111334484A (zh) | 除草剂耐受性蛋白质、其编码基因及用途 | |
CN114585731B (zh) | 突变的羟基苯丙酮酸双加氧酶多肽、其编码基因及用途 | |
WO2001007592A2 (fr) | Plantes resistant aux herbicides et procedes de production desdites plantes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20050712 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REF | Corresponds to: |
Ref document number: 60332650 Country of ref document: DE Date of ref document: 20100701 Kind code of ref document: P |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20100519 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2345147 Country of ref document: ES Kind code of ref document: T3 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100519 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100519 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100519 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100519 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100820 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100519 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100519 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100519 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100920 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100519 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100519 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100519 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100519 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100519 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100519 |
|
26N | No opposition filed |
Effective date: 20110222 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 60332650 Country of ref document: DE Effective date: 20110221 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101210 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20101120 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100519 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101210 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100519 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20100819 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 14 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 15 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20181227 Year of fee payment: 16 Ref country code: FR Payment date: 20181231 Year of fee payment: 16 Ref country code: GB Payment date: 20181221 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20190131 Year of fee payment: 16 Ref country code: DE Payment date: 20190228 Year of fee payment: 16 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 60332650 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20191210 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200701 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191210 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191231 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191231 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20210526 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191211 |